Ilan Daskal - 01 Sep 2023 Form 4 Insider Report for BIO-RAD LABORATORIES, INC. (BIO)

Role
EVP, Chief Financial Officer
Signature
/s/ Ilan Daskal
Issuer symbol
BIO
Transactions as of
01 Sep 2023
Net transactions value
-$283,323
Form type
4
Filing time
06 Sep 2023, 13:00:02 UTC
Previous filing
11 Apr 2023
Next filing
14 Nov 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BIO Bio-Rad A Common Stock Options Exercise $0 +694 +46% $0.000000 2,206 01 Sep 2023 Direct F1, F2
transaction BIO Bio-Rad A Common Stock Tax liability $94,704 -240 -11% $394.60 1,966 01 Sep 2023 Direct
transaction BIO Bio-Rad A Common Stock Options Exercise $0 +456 +23% $0.000000 2,422 01 Sep 2023 Direct F1
transaction BIO Bio-Rad A Common Stock Tax liability $82,471 -209 -8.6% $394.60 2,213 01 Sep 2023 Direct
transaction BIO Bio-Rad A Common Stock Options Exercise $0 +542 +24% $0.000000 2,755 02 Sep 2023 Direct F1
transaction BIO Bio-Rad A Common Stock Tax liability $106,147 -269 -9.8% $394.60 2,486 02 Sep 2023 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BIO Restricted Stock Units Award $0 +4,007 $0.000000 4,007 01 Sep 2023 Bio-Rad A Common Stock 4,007 $0.000000 Direct F3, F4
transaction BIO Restricted Stock Units Options Exercise $0 -694 -25% $0.000000 2,082 01 Sep 2023 Bio-Rad A Common Stock 694 $0.000000 Direct F3, F5
transaction BIO Restricted Stock Units Options Exercise $0 -456 -33% $0.000000 912 01 Sep 2023 Bio-Rad A Common Stock 456 $0.000000 Direct F3, F6
transaction BIO Restricted Stock Units Options Exercise $0 -542 -50% $0.000000 542 02 Sep 2023 Bio-Rad A Common Stock 542 $0.000000 Direct F3, F7
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares of Class A common stock acquired on the vesting of restricted stock units.
F2 Includes 18.9440 shares acquired under the Bio-Rad Employee Stock Purchase Plan on 06/30/2023.
F3 Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock.
F4 The restricted stock units vest over four years at 25% per year on the yearly anniversary date of the grant.
F5 On September 1, 2022, the reporting person was granted 2,776 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date.
F6 On September 1, 2021, the reporting person was granted 1,823 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date.
F7 On September 2, 2020, the reporting person was granted 2,166 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date.